拜耳

最新新闻

• Bayer's (BAYRY.US) application for the new indication of Finerenone tablets has been approved for listing in China.
  Zhitong Finance · 2025/1/24
• Bayer (BAYRY.US) has received approval for its first-in-class new drug.
  Zhitong Finance · 2025/7/14
• Bayer (BAYRY.US) announced that Sevabertinib has received FDA priority review for the treatment of HER2 mutated NSCLC.
  Zhitong Finance · 2025/5/29
• Barclays Initiates BAYER AG(BAYRY.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/1/7
• Bayer (BAYRY.US) subsidiary's gene therapy for Parkinson's disease has been granted advanced therapy designation by the FDA.
  Zhitong Finance · 2025/2/20
• 评级变动
  Berenberg Bank Maintains BAYER AG(BAYRY.US) With Hold Rating, Cuts Target Price to $5.8
  \u5e02\u573a\u8d44\u8baf · 2024/11/20

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。